Fall 2018 Vol. 08 Issue 03
-
From the Editor-in-Chief
CAR-T Cells: ‘Bionic’ Immune Cells for Treating CancerT cells are being rebuilt to kill cancer cells.
by William G. Nelson, MD, PhD
-
Your Cancer Guide
Gathering PerspectiveA second opinion can provide additional information to determine the best treatment course.
by Hester Hill Schnipper
-
Caregiving With Confidence
Make Your Mental Health a PriorityRecognize the signs of a serious mental illness and get help if you need it.
by Lisa O’Leary
-
Policy Matters
A Growing Commitment to Cancer SurvivorsThe number of cancer survivors is growing. We must step up efforts to meet their needs.
by Elizabeth M. Jaffee, MD
-
Moving Ahead
Cancer rehabilitation can help patients before and after treatment, but it's still not widely used.
by Cameron Walker
-
New Tactics for Bladder Cancer
After decades without treatment advances, options for patients with bladder cancer are now more numerous.
by Kendall K. Morgan
-
Raising Their Voices
People with metastatic breast cancer are demanding to be seen, counted and included in breast cancer research.
by Sue Rochman
-
Survivor Profile
The Power of PatientsJanet Freeman-Daily helps put patients at the center of lung cancer research.
by Robin Meadows
-
Q&A
A Critical ConversationPalliative care specialist Jessica Nutik Zitter offers tips to help ensure that patients' values guide end-of-life decisions.
by Marci A. Landsmann
-
Sound Advice
Your Questions, Our AnswersA patient support expert offers guidance on how to respond to news of a friend's cancer diagnosis.
-
Get Involved
Helping Kids CopeHelp with Hope delivers care packages to young people whose mother or father has received a cancer diagnosis.
by Lindsey Konkel
-
In the Moment- Fall 2018
Tanya Waring-Hearn, Amy Rowley, Elsie Young.
Reports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon